MSFT vs ABBV — Microsoft Corporation vs AbbVie Inc. Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
QuantSoar AI Verdict
ABBV is the better value pick
MSFT: $503.64 · Margin of Safety -31.0%|ABBV: $264.58 · Margin of Safety -30.0%
Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
Loading performance data...
Fundamentals & Valuation Deep Dive
Side-by-side financial metrics and valuation models.
MSFTMetricABBV
$503.64Current Price$264.58
202.75Fair Value86.78
-59.7%Margin of Safety-67.2%
28.0P/E Ratio74.5
11.3P/S Ratio7.3
8.5P/B Ratio78.8
1.11Beta0.28
$3739.8BMarket Cap$467.5B
0.01%Dividend Yield0.03%
40.3%Profit Margin9.8%
45.1%Operating Margin40.0%
34.0%ROE—
$331.8BRevenue$61.2B
21.3Forward P/E16.3
29.1Debt / Equity0.0
$577.26Analyst Target$278.56
financialProfile
Microsoft Corporation
Current Price$503.64
Fair Value$202.75
Margin of Safety-59.7%
P/E Ratio28.0
P/S Ratio11.3
P/B Ratio8.5
Beta1.1
Dividend Yield0.01%
Profit Margin40.3%
Operating Margin45.1%
ROE34.0%
Revenue$331.8B
Forward P/E21.3
Debt / Equity29.1
Analyst Target$577.26
Market Cap$3739.8B
financialProfile
AbbVie Inc.
Current Price$264.58
Fair Value$86.78
Margin of Safety-67.2%
P/E Ratio74.5
P/S Ratio7.3
P/B Ratio-78.8
Beta0.3
Dividend Yield0.03%
Profit Margin9.8%
Operating Margin40.0%
ROE—
Revenue$61.2B
Forward P/E16.3
Debt / Equity—
Analyst Target$278.56
Market Cap$467.5B
Smart Investment Matcher
Input your budget and horizon. We simulate DCA backtests and recommend the best fit.
Loading smart matcher...
Final Verdict & Actionable Takeaways
Our quantitative verdict
ABBV offers better risk-adjusted value
Based on margin of safety (ABBV wins) and beta safety (ABBV wins).
Related Stock Comparisons
Explore other popular side-by-side matchups and sector peers.